*BRAVECTO QUANTUM kills adult fleas, prevents flea infestations and treats and controls ticks (black-legged, American dog tick and brown dog tick) for 12 months. BRAVECTO QUANTUM also kills lone star ticks for 8 months.
^†BRAVECTO QUANTUM does not protect against or treat vector-borne diseases.

References

1. [Bravecto Quantum PI.] 2. Lavan R, Armstrong R, Lipworth K, Normile D, Newbury H. Flea and tick treatment satisfaction, preference, and adherence of dog owners in the United States, United Kingdom, and Australia who treated their dog with fluralaner. Open Vet J. 2020;10(2):135-143. 3. González J, Fonseca DM, Toledo A. Seasonal dynamics of tick species in the ecotone of parks and recreational areas in Middlesex County (New Jersey, USA). Insects. 2023;14(3):258. 4. McClung KL, Sundstrom KD, Lineberry MW, Grant AN, Little SE. Seasonality of Amblyomma americanum (Acari: Ixodidae) activity and prevalence of infection with tick-borne disease agents in north central Oklahoma. Vector Borne Zoonotic Dis. 2023;23(11):561-567. 5. Raghavan RK, Koestel ZL, Boorgula G, et al. Unexpected winter questing activity of ticks in the central midwestern United States. PLoS One. 2021;16(11):e0259769. 6. Dantas-Torres F. The brown dog tick, Rhipicephalus sanguineus (Latreille, 1806) (Acari: Ixodidae): from taxonomy to control. Vet Parasitol. 2008;152(3-4):173-185. 7. Blagburn BL, Dryden MW. Biology, treatment, and control of flea and tick infestations. Vet Clin North Am Small Anim Pract. 2009;39(6):1173-viii.

IMPORTANT SAFETY INFORMATION

BRAVECTO QUANTUM (fluralaner for extended-release injectable suspension) for Dogs: The most commonly reported adverse reactions in a US field study included lethargy, decreased appetite, vomiting, diarrhea, elevated liver enzymes and pruritus. BRAVECTO QUANTUM is not effective against lone star ticks beyond 8 months of dosing. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. The safety of BRAVECTO QUANTUM has not been evaluated in breeding, pregnant and lactating dogs. In some cases, adverse events have been reported following use of BRAVECTO (fluralaner) Chews in breeding females. For use in dogs and puppies 6 months of age and older. For complete safety information, refer to the product label.